This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
antibody
product name :
Human CXCL1/2/3/GRO Pan Specific Antibody
catalog :
MAB276
quantity :
100 ug (also 25 ug, 500 ug)
price :
359 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
31716
reactivity :
human
application :
western blot, neutralization, blocking or activating experiments
citations: 9
Published Application/Species/Sample/DilutionReference
  • blocking or activating experiments; human; fig s5a
Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed publisher
Gril B, Paranjape A, Woditschka S, Hua E, Dolan E, Hanson J, et al. Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases. Nat Commun. 2018;9:2705 pubmed publisher
Booth J, Duggan E, Patel V, Wu W, Burian D, Hutchings D, et al. Gene expression profiling of primary human type I alveolar epithelial cells exposed to Bacillus anthracis spores reveals induction of neutrophil and monocyte chemokines. Microb Pathog. 2018;121:9-21 pubmed publisher
Kuravi S, McGettrick H, Satchell S, Saleem M, Harper L, Williams J, et al. Podocytes regulate neutrophil recruitment by glomerular endothelial cells via IL-6-mediated crosstalk. J Immunol. 2014;193:234-43 pubmed publisher
Dong Y, Kabir S, Lee E, Son D. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-?B activation via EGFR-transactivated Akt signaling. PLoS ONE. 2013;8:e83789 pubmed publisher
Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V, et al. Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis. J Immunol. 2010;184:5263-5270 pubmed publisher
Hu H, Kwun J, Aizenstein B, Knechtle S. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation. 2009;87:1814-20 pubmed publisher
Abe Y, Fornage M, Yang C, Bui Thanh N, Wise V, Chen H, et al. L5, the most electronegative subfraction of plasma LDL, induces endothelial vascular cell adhesion molecule 1 and CXC chemokines, which mediate mononuclear leukocyte adhesion. Atherosclerosis. 2007;192:56-66 pubmed
Hagiwara H, Mitsumata M, Yamane T, Jin X, Yoshida Y. Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation. 1998;98:2584-90 pubmed
product information
brand :
R&D Systems
master code :
MAB276
SKU :
MAB276-100
product name :
Human CXCL1/2/3/GRO Pan Specific Antibody
description :
The Human CXCL1/2/3/GRO Pan Specific Antibody from R&D Systems is a mouse monoclonal antibody to CXCL1/2/3/GRO. This antibody reacts with human. The Human CXCL1/2/3/GRO Pan Specific Antibody has been validated for the following applications: Western Blot, Neutralization.
target :
CXCL1/2/3/GRO
category :
Primary Antibodies
unit size :
100 ug (also 25 ug, 500 ug)
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
clonality :
Monoclonal
clone :
31716
conjugate :
Unconjugated
host :
Mouse
immunogen :
E. coli -derived recombinant human CXCL2, Ala35-Asn107, Accession # P19875
isotype :
IgG1
purity :
Protein A or G purified from ascites
species :
Human
specificity :
Detects human CXCL1/2/3 in direct ELISAs and Western blots.
endotoxin note :
<0.10 EU per 1 µg of the antibody by the LAL method.
catalog number base :
MAB276
accessionNumbers :
P19875
applications :
Western Blot, Neutralization
2020 USD :
339
2021 USD :
359 USD
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.